Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 21, 2026.

Strengthening of the intestinal epithelial tight junction by Bifidobacterium bifidum

Chen-Yu Hsieh, Toshifumi Osaka, Eri Moriyama and 3 more

Physiological Reports · 2015 · CC BY

doi:10.14814/phy2.12327

Abstract

Epithelial barrier dysfunction has been implicated as one of the major contributors to the pathogenesis of inflammatory bowel disease. The increase in intestinal permeability allows the translocation of luminal antigens across the intestinal epithelium, leading to the exacerbation of colitis. Thus, therapies targeted at specifically restoring tight junction barrier function are thought to have great potential as an alternative or supplement to immunology-based therapies. In this study, we screened Bifidobacterium, Enterococcus, and Lactobacillus species for beneficial microbes to strengthen the intestinal epithelial barrier, using the human intestinal epithelial cell line (Caco-2) in an in vitro assay. Some Bifidobacterium and Lactobacillus species prevented epithelial barrier disruption induced by TNF-α, as assessed by measuring the transepithelial electrical resistance (TER). Furthermore, live Bifidobacterium species promoted wound repair in Caco-2 cell monolayers treated with TNF-α for 48 h. Time course (1)H-NMR-based metabonomics of the culture supernatant revealed markedly enhanced production of acetate after 12 hours of coincubation of B. bifidum and Caco-2. An increase in TER was observed by the administration of acetate to TNF-α-treated Caco-2 monolayers. Interestingly, acetate-induced TER-enhancing effect in the coculture of B. bifidum and Caco-2 cells depends on the differentiation stage of the intestinal epithelial cells. These results suggest that Bifidobacterium species enhance intestinal epithelial barrier function via metabolites such as acetate.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 21, 2026. Paragraph numbers are ours, so an answer can point at one.

Introduction

The intestinal mucosa is the dividing line between the internal and external environment, and is continuously exposed to various innocuous and noxious substances in the intestinal lumen. The intestinal epithelium is a single layer of columnar intestinal epithelial cells (IECs) that forms a physical and functional barrier preventing intestinal penetration of unwanted antigens. For the maintenance of epithelial barrier integrity, IECs are tightly bound together by intercellular junctional complexes localized at the apical-lateral membrane and along the lateral membrane (Van Itallie and Anderson ). The intercellular junctional complexes consist of the tight junctions (TJ), gap junctions (GJ), adherence junctions (AJ), and desmosome (Tsukita and Furuse; Groschwitz and Hogan; Marchiand et al. ). In particular, the apical junctional complex, encompassing the TJ (composed of claudins and occludin) and AJ (containing E-cadherin), plays a crucial role in regulating epithelial barrier functions (Laukoetter et al. ).

Intestinal permeability reflects the state of the epithelial TJ (Van Itallie and Anderson ). The TJ seals the intercellular space between adjacent epithelial cells, and is responsible for regulating selective paracellular transport of ions and solutes (e.g., nutrients) and preventing the translocation of microorganisms (both commensals and pathogens) and antigens (including bacterial toxins and food components) across the epithelium (Tsukita and Furuse; Balda and Matter ). However, some pathogens (e.g., Salmonella spp.) impair or subvert the intestinal epithelial TJ barrier, and subsequently cause acute inflammation (O'Hara and Buret ). Moreover, chronic inflammation is often associated with defective intestinal epithelial TJ barrier function that allows luminal antigens to stimulate underlying immune cells in various diseases (including celiac disease, Crohn's disease, diabetes, and food allergy) (Vogelsang et al.; Suenaert et al.; Ventura et al. ).

Intestinal permeability is affected by multiple factors including cytokines (notably TNF-α and IFN-γ), epithelial apoptosis, and exogenous factors (including alcohol, high-fat diet, nonsteroidal antiinflammatory drugs) (Ferrier et al.; Ma et al.,; Oshima et al.; Groschwitz and Hogan ). Cytokine-mediated dysregulation of intestinal barrier function has been implicated as an etiological factor for inflammatory bowel disease (IBD) and numerous autoimmune diseases (Visser et al.; Maloy and Powrie ). Especially in Crohn's disease, where TNF-α is thought to be a critical determinant of the predisposition to intestinal inflammation and a defective epithelial TJ barrier because treatment with anti-TNF-α antibodies improved impaired intestinal barrier function in Crohn's disease patients (Targan et al.; Van Deventer; Noth et al. ). TNF-α is known to be not only a proinflammatory cytokine that activates the endogenous inflammatory cascade but also a highly potent inducer of epithelial TJ disruption (Ma et al.; Ye et al.; He et al. ). The TNF-α-induced increase in intestinal TJ permeability is associated with downregulation of zonula occludens 1 (ZO-1) protein expression and an increase in myosin light chain kinase (MLCK)-mediated opening of the intestinal epithelial TJ barrier in a NF-κB-dependent manner.

Bifidobacterium species, Enterococcus species, Escherichia coli, Lactobacillus species, Streptococcus species, and Lactococcus lactis, most of which were originally isolated from healthy humans, have been used as probiotics to confer benefits to the host (De Vrese and Schrezenmeir ). Some of these probiotics have been shown to promote intestinal epithelial barrier integrity via modulation of the TJ in a strain-dependent manner (Miyauchi et al.; Sultana et al. ). Numerous previous studies showed that pretreatment of human intestinal epithelial cell lines (specifically Caco-2, HT-29, and T-84) or animal models of colitis with probiotic bacteria confers protective effects against TJ barrier impairment induced by various factors, including pathogen infection, proinflammatory cytokines, and oxidative stress (Resta-Lenert and Barrett,; Ewaschuk et al.; Ohland and MacNaughton ). These TJ-strengthening probiotics upregulated the expression of TJ proteins (notably occludin and ZO-1) or downregulated the expression of the pore-forming protein claudin-2, suggesting that probiotics directly regulate TJ barrier function at the gene expression level (Resta-Lenert and Barrett; Ewaschuk et al. ). Furthermore, probiotics modulated various protein kinase signaling pathways, which enhanced phosphorylation of TJ proteins, which can either promote TJ formation and barrier function or alternatively promote TJ protein redistribution and complex destabilization (Resta-Lenert and Barrett; Zyrek et al. ). However, the bacterial components and metabolites responsible for the TJ-strengthening effects have not yet been fully clarified.

Although protective effects on TJ integrity against harmful stimuli by pretreatment with probiotics have been well characterized as described above, there are only a limited number of studies focusing on the therapeutic effects of probiotics on impaired epithelial barrier function. In this study, we screened for beneficial microbes that promote the restoration of the intestinal epithelial barrier function under inflammatory conditions from intestinal microorganisms including Bifidobacterium, Enterococcus, and Lactobacillus species originating from human feces. The aim of this study was to investigate the mechanisms underlying the therapeutic effects of the screened bacteria. Furthermore, we tried to identify candidate metabolites responsible for the TJ-strengthening effects using 1H-NMR-based metabonomics.

Caco-2 cell culture

The human colonic adenocarcinoma epithelial cell line Caco-2 was obtained from Riken Cell Bank (Ibaraki, Japan) and kept in a humidified incubator at 37°C with 5% CO2. Caco-2 cells were maintained in Dulbecco's Modified Eagle Medium (DMEM)-High glucose (Wako, Osaka, Japan) supplemented with 10% heat-inactivated (30 min, 56°C) fetal bovine serum (Biowest, Nuaillé, France), 100 U/mL penicillin, 100 μg/mL streptomycin, and 1% nonessential amino acids (NEAA) (Wako). In this study, Caco-2 cells were used between passages 25 and 40. Cells cultivated to 80% confluence were seeded on 12-well Transwell® inserts (1.12 cm2 polycarbonate membrane with 0.4 μm pore size; Corning Life Sciences, Corning, NY) at a density of 5 × 104 cells per well. The culture medium was changed every 2 days until 20 days later when full polarization of the Caco-2 cell monolayer was achieved. The integrity of the Caco-2 cell monolayer was evaluated by measuring the transepithelial electrical resistance (TER) using a milicell-ERS (Millipore, Billerica, MA). The TER values measured in the experiments were summarized as table form below each figure, and all the figures were expressed as the relative TER value compared to the value before experimental treatment.

Bacterial isolates and sample preparation

Thirty bacterial isolates from human feces were used in this study (Table1). Each bacterial isolate was identified based on a nearly full 16S rRNA sequence, which was deposited in DNA Data Bank of Japan (DDBJ). All bacterial strains were cultured in Difco Lactobacilli MRS (de Man-Rogosa Sharpe) broth (Becton Dickinson, Sparks, MD) at 37°C under anaerobic conditions. Heat-killed bacteria were prepared by heating bacteria at 95°C for 10 min.

Evaluation of the TJ-barrier-strengthening ability of bacterial isolates

To screen the TJ-barrier-strengthening bacteria, polarized Caco-2 cell monolayers were exposed to bacterial isolates. On day 18 of cultivation, both apical and basal compartments of Caco-2 cell monolayers were washed twice with prewarmed PBS and then fresh DMEM without antibiotics added to both compartments of the Transwell® cell culture system. On day 20, the TER of each well was measured using a milicell-ERS. Caco-2 cell monolayers with >650 Ω cm2 of TER were used for further experiments. After the measurement of TER, the apical compartment of Caco-2 cell monolayers was washed with prewarmed PBS, and then the bacterial suspensions were exposed to the apical side at a multiplicity of infection (MOI, ratio of bacteria number to epithelial cell number) of 1 in a humidified incubator at 37°C with 5% CO2. Culture medium alone was used as a negative control. After 24 h incubation, the TER value was measured to assess epithelial TJ permeability. All experiments were performed in triplicate.

Evaluation of preventive effect of bacterial isolates on TNF-α-induced impairment of TJ permeability

In the prevention screening, Caco-2 cell monolayers were washed with prewarmed PBS and then bacteria (MOI of 1) added to the apical compartment one hour before TNF-α treatment. Next, the Caco-2 cell monolayers were treated with TNF-α (20 ng/mL) from the basolateral compartment to induce TJ dysfunction and incubated for a further 23 h. The TER value was measured to assess epithelial barrier function after a total of 24 h incubation. The TNF-α treated group without bacteria was used as a negative control. The prevention effect was estimated by the change in TER compared with the value before bacteria was added. All experiments except for B. bifidum WU57 were performed in triplicate. The assay of B. bifidum WU57 was performed in duplicate.

Evaluation of restorative effect of bacterial isolates on TNF-α-induced impairment of TJ permeability

Fully polarized Caco-2 cell monolayers were washed with prewarmed PBS then antibiotic-free DMEM containing TNF-α was added to the basolateral compartment. After 48 h incubation, the Caco-2 cell monolayers were washed on both the apical and basolateral sides with prewarmed PBS. Subsequently, the apical compartment of the Caco-2 cell monolayers was exposed to the bacterial suspensions at a MOI of 1. After 24 h incubation, the TER value was measured to assess the restoration of TJ function. All experiments were performed in triplicate.

RNA isolation and Gene expression analysis

Total RNA was extracted using the RNeasy mini kit (Qiagen, Tokyo, Japan) according to the manufacturer's instructions, and the RNA concentration determined by absorbance at 260/280 nm using a spectrophotometer (nano-Drop ND-1000; Thermo Scientific, Wilmington, DE). For mRNA expression analysis, cDNA was prepared from 1500 to 2000 ng of total RNA using the High-Capacity cDNA reverse transcription kit (Applied Biosystems, Carlsbad, CA) according to the manufacturer's instructions. The reverse transcription reactions were performed in a thermo cycler (iCycler, Bio-Rad, Hercules, CA) at 25°C for 10 min, 37°C for 120 min, and 85°C for 5 min. Real-Time PCR was performed with a StepOnePlus™ Real-time PCR System (Applied Biosystems) using the TaqMan® Gene Expression Assays No. Hs00268480_m1 (ZO-1), Hs00170162_m1 (occludin), Hs00221623_m1 (claudin-1), Hs00170423_m1 (E-cadherin), and Hs99999905_m1 (GAPDH) with TaqMan gene expression master mix according to the manufacturer's instructions (Applied Biosystems). The time-dependent TJ gene expression analysis during the coculture of B. bifidum WU12 and Caco-2 cells were repeated two independent times, each performed in duplicate or triplicate. The endpoint TJ gene expression analysis of Caco-2 cells treated with B. bifidum WU12 or acetate for 24 h were repeated three independent times, each performed in triplicate.

Characterization of metabolites in culture supernatants using 1H-NMR spectroscopy

Supernatants of B. bifidum monocultures and the coculture of TNF-α-treated Caco-2 cells and B. bifidum were collected at 6, 12, and 24 h. DMEM and the culture supernatants of Caco-2 cell monolayers treated with TNF-α for 48 h were also prepared. The metabolic profile of the culture supernatant was analyzed using a NMR spectrometer. The NMR samples were prepared by mixing with 10 mmol/L sodium 2,2-dimethyl-2-silapentane-5-sulfonate (DSS) dissolved in deuterium oxide (D2O) and then transferred into 5 mm NMR tubes. The spectra of these supernatant samples were obtained on a Bruker DRU-700 spectrometer equipped with an inverse (proton coils closest to the sample) gradient 5 mm cryogenically cooled 1H/13C/15N probe (Bruker Biospin, Rheinstetten, Germany), operating at 700.15 MHz for protons. The NMR measurement and data analysis of Carr–Purcell–Meiboom–Gill (CPMG) pulse sequences was performed as per previous studies (Date et al. ). The spectra acquired at 298 K, and 32,768 data point with a spectral width of 12,500 Hz were collected into 32 transients and 16 dummy scans. The NMR spectra were processed using TopSpin 3.1 software (Bruker Biospin) and assigned using the SpinAssign programs at the PRIMe web site (http://prime.psc.riken.jp/) (Chikayama et al. ). The CPMG spectra data were reduced by subdividing spectra into sequential 0.04 ppm-designated regions between 1H chemical shifts of −0.5 to 9.0 ppm. After exclusion of water resonance (4.7–5.0 ppm), each region was integrated and normalized to the total of DSS integral regions. The normalized spectra data were statistically evaluated by Principle Component Analysis (PCA) using the ‘R (2.15.2)’ software.

Determination of acetate, formate, and lactate in culture supernatants

Supernatant samples were treated with an equal volume of acetonitrile (Wako) at room temperature to precipitate proteins, and then centrifuged for 10 min at 20,000 × g at room temperature. The supernatant was collected by filtration through a 0.2 μm Advantec® disposable membrane filter unit (Toyo Roshi, Tokyo, Japan) and then stored at −80°C until analysis. Samples were diluted 100-fold in ddH2O on the eve of analysis. Acetate, formate, and lactate content in culture supernatants was determined by ICS 2100 ion chromatography (Dionex Instruments, Sunnyvale, CA) with a Dionex IonPac AS-19 column and a 1–40 mmol/L KOH gradient mobile phase.

Exploration of microorganisms strengthening tight junction barrier

After the polarized Caco-2 cell monolayers were incubated with each bacterial isolate or medium alone for 24 h, the intestinal barrier function was determined by measurement of the TER (Fig.1 and Table2). All Enterococcus isolates (including E. faecium, E. avium, E. cecorum, and E. raffinosus) induced an appreciable decrease in TER. Some Lactobacillus species (L. gasseri, L. rhamnosus, and L. salivarius) also induced a significant decrease in TER. In contrast, seven Bifidobacterium isolates and six Lactobacillus isolates induced a 5.7–33.9% increase in TER. Therefore, we examined the preventive effects of these screened isolates (7 strains of Bifidobacterium and 6 strains of Lactobacillus) on TNF-α-induced impairment of TJ permeability.

Evaluation of preventive effect of screened bacteria on TNF-α-induced impairment of tight junction function

TNF-α treatment induced a marked decrease in TER of the Caco-2 cell monolayers. Pretreatment with Lactobacillus strains did not attenuate the TNF-α-induced decrease in TER (Fig.2 and Table3). In contrast, four of the seven Bifidobacteria strains prevented the TNF-α-induced drop in TER. Interestingly, exposure to three Bifidobacteria strains (B. bifidum WU12, WU20, and WU57) led to a reproducible and significant 4.2–12.4% increase in TER (P < 0.01). Additionally, one Bifidobacteria strain (B. bifidum WU11) and two Lactobacillus strains (L. gasseri WU11 and L. pantheris WU21) demonstrated partial suppression of the TNF-α-induced TER drop, (−4.2 to −5.8% change).

Evaluation of bacteria-induced restoration of epithelial function

In this study, the addition of TNF-α (20 ng/mL) to the basolateral compartment produced an approximately 15–20% drop in Caco-2 TER for 48 h. TER of TNF-α-treated Caco-2 cell monolayers did not increase after changing to fresh medium without TNF-α, indicating no spontaneous recovery of the Caco-2 monolayer TJ function. Based on the above results, it was hypothesized that the four Bifidobacteria strains (B. bifidum strain WU12, WU20, WU57, and B. longum strain WU16) which exhibited protective effects against TNF-α induced damage could also be involved in the restoration of intestinal epithelial TJ function. Thus, we examined whether Bifidobacteria strains can restore the TJ function of Caco-2 cell monolayers damaged by the treatment of TNF-α. As a result, all tested Bifidobacterium (3 strains of B. bifidum, 1 strain of B. longum) facilitated the restoration of the Caco-2 TJ function (Fig.3 and Table4). To elucidate the mechanism of Bifidobacteria-induced epithelial restoration, B. bifidum strain WU12 was chosen for further study.

Characterization of the factor responsible for B. bifidum-induced restoration of epithelial function

We determined whether the bacterial components or secreted metabolites were responsible for the epithelial TJ restoration induced by B. bifidum strain WU12. Heat-killed B. Bifidum WU12 clearly had a diminished a repair capacity (Fig.4A and Table5A). Interestingly, only intact cells of B. bifidum strain WU12 resulted in a pronounced increase in TER of the Caco-2 cell monolayers, indicating a high repair capacity on the epithelial TJ. Thus, the interaction between live Bifidobacterium and Caco-2 cells are a prerequisite for Bifidobacteria-induced epithelial restoration. However, high-dose administration of intact bacterial cells at a MOI of 10 resulted in a significant decrease in TER of TNF-α-untreated Caco-2 cell monolayers (Fig.4B and Table5B). This might be due to the acceleration of medium acidification, as suggested by the medium turning yellow during the coculture of Caco-2 cells and live Bifidobacterium.

Modulation of the mRNA expression of tight junction proteins by B. bifidum

The kinetics of TER change during B. bifidum-induced epithelial restoration is shown in Figure5A and Table6. A rapid increase in TER was observed after 12 h of coincubation which reached 9.3% at 24 h. Quantitative RT-PCR (qRT-PCR) analysis was performed to characterize the changes in gene expression of tight junction proteins during B. bifidum-induced epithelial restoration. Although the expression dynamics of the TJ protein genes during the coincubation period were not correlated with the change in TER in Caco-2 cells incubated with B. bifidum, the administration of B. bifidum significantly enhanced the occludin mRNA expression after 24 h incubation (Fig.5B, C, and D).

Time-course characterization of the coculture supernatant

Based on the above results, it was hypothesized that metabolites produced by B. bifidum strain WU12 play a crucial role in the process of Bifidobacteria-induced epithelial restoration. To characterize the metabolic dynamics during the epithelial restoration, time-course metabolic profiles of the apical side supernatant were determined using a 1H-NMR-based metabonomics approach. The principal component analysis (PCA) of the 1H NMR chemical shift data revealed clear differences in metabolite profiles between the coculture groups, the monoculture of B. bifidum, and the monoculture of Caco-2 cell monolayers (Fig.6). Contributions of the first two components (PC1 and PC2) were 92.5% and 6.97%, respectively (Fig.6A). The loading plot analysis showed that the major metabolites contributing to the separation of each component were lactate and glucose in PC1 and acetate and formate in PC2 (Fig.6B). In the metabolite profile of B. bifidum alone group, there was only a minute amount of acetate production detected during cultivation. In the Caco-2 monoculture treated with TNF-α for 48 h, glucose was consumed and a large amount of lactate produced. In contrast, the coculture of B. bifidum and Caco-2 notably enhanced the production of acetate after 12 h of the incubation. Furthermore, formate was also produced in the coculture of B. bifidum and Caco-2.

Evaluation of the production of acetate, formate, and lactate in the coculture supernatant of Bifidobacterium isolates and Caco-2 cells

We conducted ion chromatography analysis to determine the production of acetate, formate and lactate in the supernatant during coculture of Caco-2 and B. bifidum WU12, with and without TNF-α, and by B. bifidum alone (Fig.7). Interestingly, the production of acetate and formate was amplified by the coculture of B. bifidum WU12 and Caco-2 monolayers. Acetate production in the coculture group increased 1.8 times compared with that of the monoculture of the B. bifidum strain WU12. Furthermore, we determined whether the production of acetate, formate, and lactate in the coculture supernatant differed between the seven Bifidobacterium strains, which fortified the epithelial TJ barrier of naive polarized Caco-2 cells (Fig.1). Analysis of the culture supernatant revealed that the production of lactate was mainly derived from cell metabolism of Caco-2 cells as there were no differences between the monoculture of Caco-2 and the coculture of Caco-2 and Bifidobacterium (Fig.8). In contrast, the production of acetate and formate varied among Bifidobacterium species. Notably, B. bifidum produced higher levels of acetate and formate in comparison with other species (B. adolescentis, B. longum, and B. pseudocatenulatum) (Fig.8).

Effects of acetate and formate on TJ barrier function in Caco-2 monolayers

We determined whether acetate and formate might be involved in TJ barrier restoration of Caco-2 monolayers whose TER were decreased approximately 20% by basolateral TNF-α stimulation for 48–72 h. Interestingly, administration of 10 and 20 mmol/L acetate to the apical side to the TNF-α treated Caco-2 monolayers showed a marked restorative effect after 24 h incubation (P < 0.05) (Fig.9A and Table7). On the other hand, the restorative effect of formate was weaker than the effect of acetate. Furthermore, occludin mRNA expression were significantly enhanced by apical stimulation with acetate (20 mmol/L) as the case of administration of B. bifidum WU12 (Fig.9B). Occludin mRNA levels by acetate or B. bifidum WU12 were 1.28-fold and 1.49-fold, respectively (P < 0.05). On the other hand, apical stimulation with acetate had no significant effect on the gene expression of claudin-1 and ZO-1.

Dependency of Bifidobacteria-induced TER restoration on the differentiation stage of Caco-2 cells

To investigate whether the TER-enhancing effect of B. bifidum depends on polarization of the intestinal epithelial cells, we determined the TER-enhancing activity in untreated Caco-2 cells at three different time points (Fig.10A and Table8): day 7, unpolarized; day 14, early-polarization; day 20, stable-polarization. In the early- and stable-polarization stages, the TER values of the Caco-2 cell monolayers significantly increased by approximately 30% in coculture with B. bifidum WU12. In contrast, B. bifidum-induced TER-enhancing effect in unpolarized Caco-2 cells was weak compared with that in polarized Caco-2 cells. Interestingly, the differential stage of Caco-2 cells did not affect the production of acetate and formate in the coculture of B. bifidum WU 12 and Caco-2 monolayers (Fig.10B). These results suggest that the acetate-induced TER-enhancing effect depends on the differentiation stage of the intestinal epithelial cells.

Discussion

Dysregulation of intestinal permeability allows paracellular permeation of luminal antigens that initiate or promote intestinal inflammation. Thus, a defective intestinal TJ barrier has been proposed as an etiological factor for various gastrointestinal and systemic diseases with chronic inflammation, including allergy, celiac disease, Crohn's disease, diabetes, multiple sclerosis, and irritable bowel syndrome (Arrieta et al.; Groschwitz and Hogan ). Recent studies demonstrated that various dietary components or probiotics regulate epithelial permeability by modifying intracellular signal transduction involved in the expression and localization of TJ proteins (Ulluwishewa et al. ). Administration of probiotics capable of colonizing the intestine is expected to induce long-term beneficial effects on intestinal health, whereas orally delivered dietary components have only a transient effect. In this study, we investigated the regulation of epithelial TJ barrier function by human fecal bacterial strains from the three bacterial genera (i.e., Bifidobacterium, Enterococcus, and Lactobacillus) most commonly used as probiotics for human consumption. This study demonstrated that some Bifidobacterium strains protect the epithelial TJ barrier against TNF-α-induced injury and promote the restoration of TNF-α-induced loss of epithelial barrier integrity. Furthermore, we showed that B. bifidum-induced restoration of epithelial TJ barrier may be attributed to increased production of acetate and formate, as demonstrated in cocultures of B. bifidum and Caco-2 cells.

Our present data showed that the permeability of Caco-2 epithelial cell monolayers exposed to live bacterial cells was altered depending on the bacterial strain. Many strains of Bifidobacterium species and some strains of Lactobacillus species significantly increased the TER of the Caco-2 cell monolayers, whereas all strains of Enterococcus species tested in this study dramatically decreased the TER. Therefore, in this study, we did not evaluate whether Enterococcus species have the capacity for the protection or restoration of the epithelial TJ barrier. However, these results do not mean that all of Enterococcus species are incapable of strengthening epithelial TJ function. Compared with probiotic strains belonging to the genera Bifidobacterium and Lactobacillus, Enterococcus species are used as probiotics to a much lesser extent because some strains possess virulence factors (including adhesins, invasins, pili, and hemolysin) and are resistant to various antibiotics (Franz et al. ). Steck et al. showed that a strain of the gut commensal E. faecalis compromises the epithelial barrier by metalloprotease-triggered degradation of the extracellular domain of E-cadherin (Steck et al. ). In contrast, some probiotic strains of E. faecium and E. faecalis are produced in the form of pharmaceutical preparations for treatment of diarrhea, immune modulation and lowering of serum cholesterol. Furthermore, Miyauchi et al. showed that pretreatment of heat-killed Enterococcus hirae prevented TNF-α-induced barrier impairment by modulating intracellular signaling pathways, suggesting that its cell wall components lead to the enhancement of the epithelial TJ barrier (Miyauchi et al. ). However, in this study, the heat-killed B. bifidum WU12 lost the TJ repair capacity completely. This suggests that the main inducing factor of this beneficial effect might be the metabolites of bacteria, not the cell wall components.

We found that different species of Bifidobacterium and Lactobacillus differentially attenuated TNF-α-induced reduction in TER of Caco-2 cell monolayers. Similarly, previous studies have shown that pretreatment with some commensal and probiotic bacteria can inhibit the increase in the epithelial TJ permeability caused by infection, proinflammatory cytokines, and stress (Resta-Lenert and Barrett; Donato et al.; Miyauchi et al. ). Molecular mechanisms underlying the protective effect are only partially understood. It is well established that treatment of intestinal epithelial cells with TNF-α promotes the redistribution of several TJ proteins (including claudin-1, occludin, and ZO-1) and impairs epithelial barrier function (Groschwitz and Hogan ). In particular, myosin light chain kinase (MLCK)-mediated phosphorylation of the myosin light chain (MLC), which induces the contraction of perijunctional actin–myosin filaments and opening of the epithelial TJ structure, appears to be a central molecular mechanism of TNF-α-induced loss of epithelial barrier function (Turner et al.; Zolotarevsky et al.; Ma et al.; Shen et al. ). Previous studies showed that certain probiotic and commensal bacteria (i.e., Enterococcus hirae and Lactobacillus rhamnosus) suppressed the TNF-α-induced decrease in TER of Caco-2 cell monolayers by decreasing MLCK expression (Miyauchi et al., ). Furthermore, Ye et al. revealed that the TNF-α-induced increase in MLCK expression was mediated through activation of the nuclear transcription factor NF-κB, which is considered as the master regulator of inflammatory responses (Ye et al. ). Thus, the suppression of TNF-α-induced NF-κB activation, rather than modulation of TJ proteins, is thought to be a pivotal process for prevention of TNF-α-induced barrier impairment by commensal and probiotic bacteria. In other words, beneficial bacteria that confer preventive effects against TNF-α-induced TJ disruption could also exert antiinflammatory effects on intestinal epithelial cells by inhibiting NF-κB activation.

There are only a limited number of studies focusing on the therapeutic effects of probiotics on impaired epithelial barrier function, as compared with multiple reports regarding preventive or protective effects of probiotics on TJ integrity against harmful stimuli (e.g., cytokines, infection, and H2O2). In a previous report, the probiotic E. coli Nissle 1917 led to restoration of a disrupted epithelial barrier of T84 cell monolayer caused by pathogenic E. coli infection, which was associated with increased expression and relocalization of zonula occludens-2 (ZO-2) (Zyrek et al. ). Our study demonstrated that Bifidobacterium species promoted the restoration of the epithelial TJ barrier of Caco-2 cell monolayer, in which TJ barrier integrity was impaired by pretreatment of TNF-α. Notably; B. bifidum WU12 exerted the highest TER-restorative effect on Caco-2 cell monolayers among the tested Bifidobacterium strains. Interestingly, B. bifidum-induced increase in TER was accompanied by an increase in mRNA expression of occludin. Balda et al. showed that the overexpression of occludin was linked to an increase in TER (Balda et al. ). From these findings, increased occludin gene expression may contribute to the ability of B. bifidum to restore the epithelial TJ barrier. In contrast, B. bifidum did not alter the mRNA expression of other TJ-related proteins (i.e., claudin-1 and ZO-1). In previous studies, the treatment of epithelial monolayers with probiotics (specifically L. rhamnosus GG, L. plantarum, and L. salivarius) enhanced protein expression of the occludin-associated plaque proteins (ZO-1, ZO-2, and cingulin) and other TJ-related proteins (claudin-1, claudin-3, and JAM-1) by IECs (Anderson et al.; Miyauchi et al.; Patel et al. ). Thus, epithelial barrier integrity may be further enhanced by administration of a mixture of multiple probiotic species each capable of modulating specific TJ proteins. Furthermore, the paracellular permeability of IECs are affected by expression levels and localization of TJ proteins in the paracellular space. Further study assaying the expression level and localization of TJ proteins during the B. bifidum-induced TJ restoration will be carried out to elucidate the cellular mechanisms.

Live B. bifidum had a restorative effect on the TER in TJ-impaired Caco-2 cell monolayers, whereas this effect was diminished when treated with heat-killed bacteria. It was previously reported that metabolites from B. infantis or B. lactis prevented epithelial barrier dysfunction caused by proinflammatory cytokines or pathogen infection (Ewaschuk et al.; Putaala et al. ). Thus, we speculate that some of B. bifidum-derived metabolites may also regulate the epithelial TJ. In this study, NMR-based metabonomics analysis of the coculture supernatant revealed that SCFAs (acetate and formate) are responsible for the TER-restorative effect induced by live B. bifidum. Interestingly, production of acetate and formate was upregulated in the coculture environment compared with the monoculture of Bifidobacterium strain or Caco-2 monolayers, indicating that cross talk between the host and microbes may alter their metabolic activity. Further studies are needed to clarify which cells enhanced the production of acetate or formate by coculture. Furthermore, we observed that production levels of acetate and formate in the coculture varied depending on the Bifidobacterium strain. There are previous reports showing the beneficial effect of SCFAs on TER and paracellular permeation in Caco-2 cell monolayers (Mariadason et al.; Malago et al.; Suzuki et al.; Elamin et al. ). Notably, Suzuki et al. presented the finding that the incubation of Caco-2 cell monolayers with acetate (>40 mmol/L) led to a significant increase in the epithelial TJ barrier function. They suggested that acetate-induced TJ enforcement may be mediated by intracellular signal transduction through GPR43, which has been defined as one of the cell surface G-protein coupled receptors for SCFAs (Brown et al.; Suzuki et al. ). However, the molecular mechanism underlying acetate-mediated fortification of intestinal epithelial barrier remains unclear. In contrast, our data suggest that B. bifidum-induced epithelial TJ enforcement was dependent on the differentiation stage of Caco-2 cell monolayers. In future experiments we will elucidate the molecular mechanism involved, including the investigation of the GPR43-acetate signaling pathway.

Probiotic microorganisms (e.g., Bifidobacterium and Lactobacillus) exert their immune-modulatory effect through interaction with Toll-like receptor 2 (TLR2), which recognizes cell wall components such as peptidoglycan, lipoteichoic acid, and lipoprotein (Mohamadzadeh et al.; Galdeano and Perdigon; Hoarau et al.; Zeuthen et al. ). Furthermore, recent studies have shown that TLR2 stimulation plays a crucial role in maintaining intestinal epithelial barrier integrity. Stimulation with the synthetic TLR2 agonist PCSK efficiently preserves TJ-associated barrier integrity (Cario et al., ). Cell wall components derived from some Bifidobacterium and Enterococcus strains are also reported to markedly enhance epithelial TJ barrier through a TLR2-mediated mechanism (Miyauchi et al.; Sultana et al. ). This study showed that heat-killed B. bifidum slightly increased TER of Caco-2 cell monolayers, whereas lipase and mutanolysin treatment to digest lipid-related components abolished the rise in TER elicited by B. bifidum. These results suggest that cross talk between B. bifidum and TLR2 plays a partial role in the modulation of intestinal epithelial TJ barrier function.

In summary, we demonstrated that most of Bifidobacterium strains have the capacity to prevent TNF-α-induced disruption of intestinal epithelial barrier and to promote epithelial TJ integrity. Furthermore, it was found that the upregulation of the production of SCFAs (acetate and formate) leads to the restoration of the epithelial TJ barrier. Our findings show that TJ-strengthening Bifidobacterium strains could make an important contribution to the prevention and treatment of various digestive system disorders associated with intestinal epithelial barrier dysfunction (including diabetes, inflammatory bowel disease, and nonalcoholic fatty liver disease). However, studies using animal models are still required to evaluate in vivo the beneficial effects seen here in vitro.

Conflict of Interest

The authors have no conflicts of interest to disclose.

References 57

  1. 1.
  2. 2.

    Arrieta MC, Bistritz L, Meddings JB. Alterations in intestinal permeability. Gut. 2006;55:1512-1520.

    Not in our library10.1136/gut.2005.085373

  3. 3.

    Balda MS, Matter K. Tight junctions at a glance. J. Cell Sci. 2008;121:3677-3682.

    Not in our library10.1242/jcs.023887

  4. 4.

    Balda MS, Whitney JA, Flores C, Gonzalez S, Cereijido M, Matter K. Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J. Cell Biol. 1996;134:1031-1049.

    Not in our library10.1083/jcb.134.4.1031

  5. 5.

    Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, et al. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 2003;278:11312-11319.

    Not in our library10.1074/jbc.m211609200

  6. 6.

    Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology. 2004;127:224-238.

    Not in our library10.1053/j.gastro.2004.04.015

  7. 7.

    Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology. 2007;132:1359-1374.

    Not in our library10.1053/j.gastro.2007.02.056

  8. 8.

    Chikayama E, Sekiyama E, Okamoto M, Nakanishi Y, Tsuboi Y, Akiyama K, et al. Statistical indices for simultaneous large-scale metabolite detections for a single NMR spectrum. Anal. Chem. 2010;82:1653-1658.

    Not in our library10.1021/ac9022023

  9. 9.

    Date Y, Sakata K, Kikuchi J. Chemical profiling of complex biochemical mixtures from various seaweeds. J. Polymer. 2012;44:888-894.

    Not in our library

  10. 10.

    De Vrese M, Schrezenmeir J. Probiotics, prebiotics, synbiotics. Adv. Biochem. Eng. Biotechnol. 2008;111:1-66.

    Not in our library10.1007/10_2008_097

  11. 11.

    Donato KA, Gareau MG, Wang YJJ, Sherman PM. Lactobacillus rhamnosus GG attenuates interferon-γ and tumour necrosis factor-α-induced barrier dysfunction and pro-inflammatory signaling. Microbiology. 2010;156:3288-3297.

    Not in our library10.1099/mic.0.040139-0

  12. 12.

    Elamin EE, Masclee AA, Dekker J, Pieters HJ, Jonkers D M. Short-chain fatty acids activate AMP-activated protein kinase and ameliorate ethanol-induced intestinal barrier dysfunction in Caco-2 cell monolayers. J. Nutr. 2013;143:1872-1881.

    Not in our library10.3945/jn.113.179549

  13. 13.

    Ewaschuk JB, Diaz H, Meddings L, Diederichs B, Dmytrash A, Backer J, et al. Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am. J. Physiol. Gastrointest. Liver Physiol. 2008;295:G1025-G1034.

    Not in our library10.1152/ajpgi.90227.2008

  14. 14.

    Ferrier L, Berard F, Debrauwer L, Chabo C, Langella P, Bueno L, et al. Impairment of the intestinal barrier by ethanol involves enteric microflora and mast cell activation in rodents. Am. J. Pathol. 2006;168:1148-1154.

    Not in our library10.2353/ajpath.2006.050617

  15. 15.

    Franz CMAP, Huch M, Abriouel H, Holzapfel W, Gálvez A. Enterococci as probiotics and their implications in food safety. Int. J. Food Microbiol. 2011;151:125-140.

    Not in our library10.1016/j.ijfoodmicro.2011.08.014

  16. 16.

    Galdeano CM, Perdigon G. The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity. Clin. Vaccine Immunol. 2006;13:219-226.

    Not in our library10.1128/cvi.13.2.219-226.2006

  17. 17.

    Groschwitz KR, Hogan SP. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin. Immunol. 2009;124:3-20.

    Not in our library10.1016/j.jaci.2009.05.038

  18. 18.

    He F, Peng J, Deng XL, Yang LF, Camara AD, Omran A, et al. Mechanisms of tumor necrosis factor-alpha-induced leaks in intestine epithelial barrier. Cytokine. 2012;59:264-272.

    Not in our library10.1016/j.cyto.2012.04.008

  19. 19.

    Hoarau C, Lagaraine C, Martin L, Velge-Roussel F, Lebranchu Y. Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a Toll-like receptor 2 pathway. J. Allergy Clin. Immun. 2006;117:696-702.

    Not in our library10.1016/j.jaci.2005.10.043

  20. 20.

    Laukoetter MG, Bruewer M, Nusrat A. Regulation of the intestinal epithelial barrier by the apical junctional complex. Curr. Opin. Gastroenterol. 2006;22:85-89.

    Not in our library10.1097/01.mog.0000203864.48255.4f

  21. 21.

    Ma TY, Boivin MA, Ye D, Pedram A, Said HM. Mechanism of TNF-α modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression. Am. J. Physiol. Cell Physiol. 2005;288:G422-G430.

    Not in our library10.1152/ajpgi.00412.2004

  22. 22.

    Ma TY, Iwamoto GK, Hoa NT, Akotia V, Pedram A, Boivin MA, et al. TNF-α-induced increase in intestinal epithelial tight junction permeability requires NF-κB activation. Am. J. Physiol. Gastrointest. Liver Physiol. 2006;290:G496-G504.

    Not in our library10.1152/ajpgi.00173.2003

  23. 23.

    Ma X, Torbenson M, Hamad AR, Soloski MJ, Li Z. High-fat diet modulates non-CD1d-restricted natural killer T cells and regulatory T cells in mouse colon and exacerbates experimental colitis. Clin. Exp. Immunol. 2008;151:130-138.

    Not in our library10.1111/j.1365-2249.2007.03530.x

  24. 24.

    Malago JJ, Koninkx JF, Douma PM, Dirkzwager A, Veldman A, Hendriks HG, et al. Differential modulation of enterocyte-like Caco-2 cells after exposure to short-chain fatty acids. Food Addit. Contam. 2003;20:427-437.

    Not in our library10.1080/0265203031000137728

  25. 25.

    Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature. 2011;474:298-306.

    Not in our library10.1038/nature10208

  26. 26.

    Marchiand AM, Graham WV, Turner JR. Epithelial barriers in homeostasis and disease. Annu. Rev. Pathol. 2010;5:119-144.

    Not in our library10.1146/annurev.pathol.4.110807.092135

  27. 27.

    Mariadason JM, Barkla DH, Gibson PR. Effect of short-chain fatty acids on paracellular permeability in Caco-2 intestinal epithelium model. Am. J. Physiol. 1997;272:G705-G712.

    Not in our library10.1152/ajpgi.1997.272.4.g705

  28. 28.

    Miyauchi E, Morita H, Okuda J, Sashihara T, Shimizu M, Tanabe S. Cell wall fraction of Enterococcus hirae ameliorates TNF-α-induced barrier impairment in the human epithelial tight junction. Lett. Appl. Microbiol. 2008;46:469-476.

    Not in our library10.1111/j.1472-765x.2008.02332.x

  29. 29.

    Miyauchi E, Morita H, Tanabe S. Lactobacillus rhamnosus alleviates intestinal barrier dysfunction in part by increasing expression of zonula occludens-1 and myosin light-chain kinase in vivo. J. Dairy Sci. 2009;92:2400-2408.

    Not in our library10.3168/jds.2008-1698

  30. 30.

    Miyauchi E, O'Callaghan J, Buttó LF, Hurley G, Melgar S, Tanabe S, et al. Mechanism of protection of transepithelial barrier function by Lactobacillus salivarius: strain dependence and attenuation by bacteriocin production. Am. J. Physiol. Gastrointest. Liver Physiol. 2012;303:G1029-G1041.

    Not in our library10.1152/ajpgi.00003.2012

  31. 31.

    Mohamadzadeh M, Olson S, Kalina WV, Ruthel G, Demmin GL, Warfield KL, et al. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc. Natl Acad. Sci. USA. 2005;102:2880-2885.

    Not in our library10.1073/pnas.0500098102

  32. 32.

    Noth R, Stüber E, Häsler R, Nikolaus S, Kühbacher T, Hampe J, et al. Anti-TNF-α antibodies improve intestinal barrier function in Crohn's disease. J. Crohns. Colitis. 2012;6:464-469.

    Not in our library10.1016/j.crohns.2011.10.004

  33. 33.

    O'Hara JR, Buret AG. Mechanism of intestinal tight junctional disruption during infections. Front Biosci. 2008;112:266-274.

    Not in our library10.2741/3206

  34. 34.

    Ohland CL, MacNaughton WK. Probiotic bacteria and intestinal epithelial barrier function. Am. J. Physiol. Gastrointest. Liver Physiol. 2010;298:G807-G819.

    Not in our library10.1152/ajpgi.00243.2009

  35. 35.

    Oshima T, Miwa H, Joh T. Aspirin induces gastric epithelial barrier dysfunction by activating p38 MAPK via claudin-7. Am. J. Physiol. Cell Physiol. 2008;295:C800-C806.

    Not in our library10.1152/ajpcell.00157.2008

  36. 36.

    Patel RM, Myers LS, Kurundkar AR, Maheshwari A, Nusrat A, Lin PW. Probiotic bacteria induce maturation of intestinal claudin 3 expression and barrier function. Am. J. Pathol. 2012;180:626-635.

    Not in our library10.1016/j.ajpath.2011.10.025

  37. 37.

    Putaala H, Salusjarvi T, Nordstrom M, Saarinen M, Ouwehand AC, Bech Hansen E, et al. Effect of four probiotic strains and Escherichia coli O157:H7 on tight junction integrity and cyclooxygenase expression. Res. Microbiol. 2008;159:692-698.

    Not in our library10.1016/j.resmic.2008.08.002

  38. 38.

    Resta-Lenert S, Barrett KE. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut. 2003;52:988-997.

    Not in our library10.1136/gut.52.7.988

  39. 39.

    Resta-Lenert S, Barrett KE. Probiotics and commensals reverse TNF-α- and IFN-γ-induced dysfunction in human intestinal epithelial cells. Gastroenterology. 2006;130:731-746.

    Not in our library10.1053/j.gastro.2005.12.015

  40. 40.

    Shen L, Black ED, Witkowski ED, Lencer WI, Guerriero V, Schneeberger EE, et al. Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J. Cell Sci. 2006;119:2095-2106.

    Not in our library10.1242/jcs.02915

All 57 references

Cited by papers we hold 10

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.